CHENGDU SHENGNUO BIOPHARM CO LTD

Overview

CHENGDU SHENGNUO BIOPHARM CO LTD is an active pharmaceutical ingredient (API) supplier with 13 active FDA Type II Drug Master Files, covering BIVALIRUDIN (NON-STERILE BULK DRUG); EPTIFIBATIDE; GANIRELIX ACETATE; ICATIBANT ACETATE; LANREOTIDE ACETATE; LINACLOTIDE.

API / Drug Master Files

CHENGDU SHENGNUO BIOPHARM CO LTD holds 13 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RETATRUTIDEActive2026-03-30
• TIRZEPATIDEActive2025-11-26
• LANREOTIDE ACETATEActive2024-06-14
• SEMAGLUTIDE NON-STERILE BULK DRUGActive2023-10-23
• LINACLOTIDEActive2021-04-06
• GANIRELIX ACETATEActive2019-12-13
• ZICONOTIDE ACETATEActive2019-04-11
• TERIPARATIDEActive2019-02-04
• OCTREOTIDE ACETATE USPActive2016-09-20
• LIRAGLUTIDEActive2015-10-07
• ICATIBANT ACETATEActive2015-03-09
• EPTIFIBATIDEActive2013-12-19
• BIVALIRUDIN (NON-STERILE BULK DRUG)Active2012-05-14
• LIRAGLUTIDEInactive2014-06-23

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHENGDU SHENGNUO BIOPHARM CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.